P
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A313.5 KBPROGENICS PHARMACEUTICALS INCFeb 8, 12:00 PM ET·0000908834-22-000053
- SC 13G/A296.8 KBPROGENICS PHARMACEUTICALS INCFeb 12, 6:42 PM ET·0001214659-21-001720
- SC 13D/A50.7 KBPROGENICS PHARMACEUTICALS INCJun 23, 10:26 AM ET·0001193125-20-176191
- 8-K110.1 KBPROGENICS PHARMACEUTICALS INCJun 22, 7:55 AM ET·0001193125-20-174778
- 8-K22.2 KBPROGENICS PHARMACEUTICALS INCJun 17, 5:16 PM ET·0001193125-20-171462
- 8-K35.6 KBPROGENICS PHARMACEUTICALS INCJun 16, 5:02 PM ET·0001193125-20-170487
- 8-K22.9 KBPROGENICS PHARMACEUTICALS INCJun 11, 4:46 PM ET·0001437749-20-012911
- 8-K82.2 KBPROGENICS PHARMACEUTICALS INCJun 8, 4:54 PM ET·0001193125-20-163566
- SC 13G/A8.1 KBPROGENICS PHARMACEUTICALS INCJun 4, 4:06 PM ET·0000790502-20-000009
- 8-K24.7 KBPROGENICS PHARMACEUTICALS INCMay 28, 4:03 PM ET·0001437749-20-011934
Insiders
10- BAKER CHARLES ADirector
- Baker Mark RobertGeneral Counsel
- Ber GerardDirector
- Boyd Thomas ASr. VP, Product Dev.
- BRINER KURT WDirector
- Broadfin Capital, LLC10% Owner
- Broadfin Healthcare Master Fund Ltd10% Owner
- Campbell Bradley LDirector
- Cooke Terence10% Owner, See Explanation of Responses
- Crowley Peter JDirector
Tickers
No tickers on record
Addresses
business
ONE WORLD TRADE CENTER 47TH FLOOR
NEW YORK, NY, 10007
mailing
ONE WORLD TRADE CENTER 47TH FLOOR
NEW YORK, NY, 10007